Dbriefs
30 Apr.

Emerging artificial intelligence policy

Life Sciences & Health Care

Tuesday, 02:00 p.m.  ET | 1 hr
Credits offered: CPE Event language: English

Participants will review outstanding questions yet to be answered through policymaking to help equip them with information in order to enhance strategic discussions for their organization.

Register

Key takeaways

Host: Asif Dhar, US Life Sciences and Health Care industry leader, Deloitte Consulting LLP

Presenters: Jay Bhatt, managing director, Deloitte Services LP
                      Bill Fera, principal, Deloitte Consulting LLP
                      Anne Phelps, principal, Deloitte & Touche LLP 

1.0 Overview CPE credit | Specialized Knowledge

In the emerging artificial intelligence (AI) policy landscape, regulating the use of AI in health care and life sciences is one of the highest priorities as the use of AI in health care carries risk. During this webcast, we’ll discuss:

  • Issues such as data bias, transparency, security, and the HIPAA privacy law
  • Possible implications of policy activity on stakeholders
  • How multiple government agencies, including those that haven’t historically regulated the health care industry, are exercising enforcement authorities over health information

Meet the speakers

Dr. Asif Dhar

Dr. Asif Dhar

Industry Leader | Life Sciences and Health Care

Dr. Dhar is vice chair and US Life Sciences and Health Care (LSHC) Industry Leader for Deloitte LLP leading the overall strategic direction for the life sciences and health care practices, including audit, consulting, tax, and advisory services. He helps Governments, Life Sciences and Health Care clients reinvent wellness, address disease, respond to pandemics and tackle health inequities. Dr. Dhar's teams have developed powerful view of the Future of Health which explains how health will leverage disruptive technologies to transform the industry to make it consumer focused, personalized, preventative, equitable and sustainable. He has a deep passion for climate, sustainability and equity and is an executive sponsor for Deloitte’s Health Equity Institute. Dr. Dhar has a deep interest in cancer that goes well beyond his day to day business responsibilities at Deloitte. He is a board member of the American Cancer Society and works with numerous organizations to end cancer as we know it.

Dr. Jay Bhatt

Dr. Jay Bhatt

Managing Director, Deloitte Center for Health Solutions and Deloitte Health Equity Institute

Dr. Jay Bhatt is a physician executive, primary care physician, and public health innovator. As managing director of the Deloitte Center for Health Solutions and the Deloitte Health Equity Institute, Bhatt directs the firm's research and insights agenda across the life sciences and health care industry. Dr. Bhatt continues to practice medicine in the Chicago area while serving in his leadership role at Deloitte.

Bill Fera, MD

Bill Fera, MD

Principal | Deloitte Consulting LLP

Bill Fera, MD, is a principal, Deloitte Consulting LLP. Bill specializes in technology-enabled transformation to support the advancement of population health strategies. As a practicing physician, health system executive, and consultant, Bill has worked across health plans and health systems to drive toward a value-based, patient-centered model of care. He is based in Pittsburgh, PA.

Anne Phelps

Anne Phelps

Principal

Anne Phelps is a Deloitte & Touche LLP principal in the Life Sciences and Health Care practice. As the US Health Care Regulatory leader for Deloitte, she manages the Health Care Strategic Regulatory Implementation Services practice. In this capacity, she helps clients navigate the complex world of health care regulatory changes to set their business priorities and strategic opportunities in the midst of a dynamic environment.

Resources

Recommended for you

Tuesday, 30 Apr 2024 02:00 p.m. ET
Share Share event on social
Register